XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Cash flows from operating activities:    
Net income $ 303,260 $ 391,529
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 27,715 28,917
Deferred income taxes 1,089 1,817
Depreciation 49,407 42,168
Amortization of intangibles 41,684 38,151
Change in operating assets and liabilities:    
Decrease in accounts receivable 96,955 57,897
Increase in inventories (8,139) (83,973)
Increase in other current assets (16,776) (6,259)
Increase in other assets (2,612) (9,302)
Increase (decrease) in accounts payable and other current liabilities 46,721 (493)
Increase in deferred revenue and customer advances 32,053 34,926
Effect of the 2017 Tax Cuts & Jobs Act   (3,229)
Decrease in other liabilities (48,332) (40,957)
Net cash provided by operating activities 523,025 451,192
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (125,340) (110,205)
Business acquisitions, net of cash acquired (76,664)  
Investment in unaffiliated companies (3,850) (7,250)
Purchases of investments (22,458) (35,523)
Maturities and sales of investments 1,751 978,419
Net cash (used in) provided by investing activities (226,561) 825,441
Cash flows from financing activities:    
Proceeds from debt issuances 315,000 600,362
Payments on debt (425,366) (390,482)
Payments of debt issuance costs   (2,932)
Proceeds from stock plans 28,421 34,311
Purchases of treasury shares (196,353) (1,909,700)
Proceeds from derivative contracts 10,330 6,900
Net cash used in financing activities (267,968) (1,661,541)
Effect of exchange rate changes on cash and cash equivalents 10,723 (6,723)
Increase (decrease) in cash and cash equivalents 39,219 (391,631)
Cash and cash equivalents at beginning of period 335,715 796,280
Cash and cash equivalents at end of period $ 374,934 $ 404,649